Skip to main content
. 2023 May 23;100(21):1010–1019. doi: 10.1212/WNL.0000000000206891

Figure. The 5-Step AD Biomarker Disclosure Process.

Figure

This disclosure process is to be led by a knowledgeable clinician and embedded within the individual's ongoing participation in research or receipt of care, which is understood to include cognitive testing and capacity assessment. AD = Alzheimer disease.